 | Epizyme Inc (NASDAQ:EPZM) Expected to Announce Earnings of -$0.56 Per Share
www.americanbankingnews.com - July 14 at 4:33 PM |
| Epizyme Inc (NASDAQ:EPZM) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - July 9 at 2:20 AM |
 | Epizyme (NASDAQ:EPZM) Lowered to "Strong Sell" at BidaskClub
www.marketbeat.com - July 7 at 1:27 AM |
 | Epizyme A Buy For Tazverik And Epigenetic Platform - Seeking Alpha
seekingalpha.com - July 1 at 9:37 AM |
| Epizyme Inc (NASDAQ:EPZM) CEO Sells $77,083.95 in Stock
www.americanbankingnews.com - June 30 at 11:32 AM |
| Paolo Tombesi Sells 1,805 Shares of Epizyme Inc (NASDAQ:EPZM) Stock
www.marketbeat.com - June 30 at 11:32 AM |
 | Monday 6/29 Insider Buying Report: BSIG, EPZM
www.nasdaq.com - June 30 at 8:23 AM |
 | Insider Buying: The Epizyme, Inc. (NASDAQ:EPZM) Independent Chairman Just Bought 49% More Shares - Yahoo Finance
finance.yahoo.com - June 28 at 1:00 PM |
| Insider Buying: The Epizyme, Inc. (NASDAQ:EPZM) Independent Chairman Just Bought 49% More Shares
finance.yahoo.com - June 28 at 1:00 PM |
| Epizyme Inc (NASDAQ:EPZM) Director David M. Mott Buys 62,019 Shares
www.americanbankingnews.com - June 26 at 8:31 PM |
|
| $4.45 Million in Sales Expected for Epizyme Inc (NASDAQ:EPZM) This Quarter
www.americanbankingnews.com - June 24 at 3:43 AM |
| Insider Selling: Epizyme Inc (NASDAQ:EPZM) CEO Sells 20,000 Shares of Stock
www.americanbankingnews.com - June 22 at 9:03 PM |
| Epizyme Inc (NASDAQ:EPZM) Insider Matthew Ros Sells 112,003 Shares
www.americanbankingnews.com - June 22 at 8:31 PM |
| Epizyme (NASDAQ:EPZM) Shares Gap Down Following Analyst Downgrade
www.marketbeat.com - June 22 at 1:53 PM |
| Brokerages Anticipate Epizyme Inc (NASDAQ:EPZM) to Post -$0.56 Earnings Per Share
www.americanbankingnews.com - June 22 at 9:50 AM |
 | Epizyme's shares fall after receiving new FDA approval for cancer drug
www.msn.com - June 21 at 7:22 AM |
 | BRIEF-Roche Gets FDA Approval For Cobas EZH2 Mutation Test As Companion Diagnostic For Tazverik Developed By Epizyme - Reuters
www.reuters.com - June 19 at 7:07 PM |
| FDA OK companion diagnostic for Epizyme's Tazverik - Seeking Alpha
seekingalpha.com - June 19 at 2:06 PM |
 | Epizyme's shares fall after receiving new FDA approval for cancer drug - MarketWatch
www.marketwatch.com - June 19 at 2:06 PM |
| Epizyme's shares fall after receiving new FDA approval for cancer drug
finance.yahoo.com - June 19 at 9:00 AM |
| Cigna's Tie-Up to Offer Improved Healthcare in North Alabama - Nasdaq
www.nasdaq.com - June 19 at 12:24 AM |
 | Cowen Defends Epizyme (EPZM) on Label Concerns - StreetInsider.com
www.streetinsider.com - June 18 at 7:23 PM |
| FDA OKs Epizyme's tazemetostat for treatment-resistant follicular lymphoma - Seeking Alpha
seekingalpha.com - June 18 at 2:23 PM |
 | Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for Relapsed/Refractory Follicular Lymphoma - Business Wire
www.businesswire.com - June 18 at 2:23 PM |
| Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for Relapsed/Refractory Follicular Lymphoma
finance.yahoo.com - June 18 at 2:23 PM |
 | The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions - Benzinga
www.benzinga.com - June 18 at 9:23 AM |
| Hedge Funds Aren’t Done Buying Epizyme Inc (EPZM) - Yahoo Finance
finance.yahoo.com - June 17 at 6:50 PM |
 | 2 Top Cancer Treatment Stocks to Buy in June - Motley Fool
www.fool.com - June 16 at 9:14 AM |
| Call Buying Activity in Epizyme (EPZM) Targets 57% Upside in Shares Through Mid-August -Susquehanna - StreetInsider.com
www.streetinsider.com - June 13 at 12:07 AM |
| Epizyme (EPZM) Down 4.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
finance.yahoo.com - June 3 at 7:33 PM |
|
| Epizyme (EPZM) Down 4.4% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 3 at 2:32 PM |
| Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates - Yahoo Finance
finance.yahoo.com - June 1 at 7:34 PM |
| Epizyme, Inc. Is Doing Everything Right But Its Shares Appear Fairly Priced - Seeking Alpha
seekingalpha.com - May 27 at 12:48 PM |
| Epizyme (EPZM): Strong Industry, Solid Earnings Estimate Revisions - Yahoo Finance
finance.yahoo.com - May 14 at 12:52 PM |
| Epizyme (EPZM): Strong Industry, Solid Earnings Estimate Revisions
finance.yahoo.com - May 14 at 12:52 PM |
| BRIEF-Epizyme To Present Data From Tazemetostat Clinical Program During 2020 ASCO Virtual Scientific Program - Reuters
www.reuters.com - May 13 at 9:16 PM |
| Epizyme to Present Data from Tazemetostat Clinical Program during the 2020 ASCO Virtual Scientific Program - Business Wire
www.businesswire.com - May 13 at 9:16 PM |
| Epizyme to Present Data from Tazemetostat Clinical Program during the 2020 ASCO Virtual Scientific Program
finance.yahoo.com - May 13 at 9:16 PM |
| Allogene's (ALLO) Q1 Loss Widens Y/Y, Pipeline Progresses - Yahoo Finance
finance.yahoo.com - May 7 at 12:26 PM |
| Allogene's (ALLO) Q1 Loss Widens Y/Y, Pipeline Progresses
finance.yahoo.com - May 7 at 12:26 PM |
| Edited Transcript of EPZM earnings conference call or presentation 4-May-20 1:00pm GMT - Yahoo Finance
finance.yahoo.com - May 5 at 5:28 PM |
| Epizyme's (EPZM) Q1 Earnings Beat Estimates, Revenues Miss - Yahoo Finance
finance.yahoo.com - May 5 at 5:28 PM |
| Epizyme's (EPZM) Q1 Earnings Beat Estimates, Revenues Miss
finance.yahoo.com - May 5 at 5:28 PM |
| Edited Transcript of EPZM earnings conference call or presentation 4-May-20 1:00pm GMT
finance.yahoo.com - May 5 at 8:49 AM |
| Epizyme Inc (EPZM) Q1 2020 Earnings Call Transcript - Motley Fool
www.fool.com - May 4 at 10:44 PM |
| Epizyme Inc (EPZM) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 4 at 10:44 PM |
| Epizyme Reports Business Progress and First Quarter 2020 Financial Results - Business Wire
www.businesswire.com - May 4 at 5:44 PM |
| Epizyme (EPZM) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
finance.yahoo.com - May 4 at 5:44 PM |
| BRIEF-Epizyme Posts Q1 Loss Per Share Of $0.51 - Reuters
www.reuters.com - May 4 at 12:43 PM |
| Epizyme (EPZM) Tops Q1 EPS by 23c, Revenues Miss - StreetInsider.com
www.streetinsider.com - May 4 at 12:43 PM |
